Relevance of the Core 70 and IL-28B polymorphism and response-guided therapy of peginterferon alfa-2a ± ribavirin for chronic hepatitis C of Genotype 1b: a multicenter randomized trial, ReGIT-J study

Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients

(2012) Shiho Miyase et al.   JOURNAL OF GASTROENTEROLOGY

Refined prediction of week 12 response and SVR based on week 4 response in HCV genotype 1 patients treated with peginterferon alfa-2a (40KD) and ribavirin

(2012) Patrick Marcellin et al.   JOURNAL OF HEPATOLOGY

Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: Meta-analyses of randomized, controlled trials and implications for the future

(2011) Vincent Di Martino et al.   HEPATOLOGY

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

(2011) Hiromitsu Kumada et al.   JOURNAL OF HEPATOLOGY

Predictive value of early viral dynamics during peginterferon and ribavirin combination therapy based on genetic polymorphisms near the IL28B gene in patients infected with HCV genotype 1b

(2011) Hidenori Toyoda et al.   JOURNAL OF MEDICAL VIROLOGY

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

(2011) N. Hayashi et al.   JOURNAL OF VIRAL HEPATITIS

Response-guided and -unguided treatment of chronic hepatitis C

(2011) K. Rajender Reddy et al.   LIVER INTERNATIONAL

Meta-analysis Shows Extended Therapy Improves Response of Patients With Chronic Hepatitis C Virus Genotype 1 Infection

(2010) Harald Farnik et al.   Clinical Gastroenterology and Hepatology

Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response

(2010) Stefan Zeuzem et al.   CURRENT MEDICAL RESEARCH AND OPINION

Interleukin-28B Polymorphism Improves Viral Kinetics and Is the Strongest Pretreatment Predictor of Sustained Virologic Response in Genotype 1 Hepatitis C Virus

(2010) Alexander J. Thompson et al.   GASTROENTEROLOGY

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C

(2010) Gowtham A. Rao et al.   GASTROENTEROLOGY

Individualisation of antiviral therapy for chronic hepatitis C

(2010) Narci C Teoh et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy

(2010) Tsugiko Oze et al.   JOURNAL OF HEPATOLOGY

Pre-treatment prediction of response to pegylated-interferon plus ribavirin for chronic hepatitis C using genetic polymorphism in IL28B and viral factors

(2010) Masayuki Kurosaki et al.   JOURNAL OF HEPATOLOGY

Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response

(2009) Peter Ferenci et al.   GASTROENTEROLOGY

An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads

(2009) Hitomi Sezaki et al.   INTERVIROLOGY

Reduced risk of hepatocellular carcinoma after interferon therapy in aged patients with chronic hepatitis C is limited to sustained virological responders

(2009) Y. Imai et al.   JOURNAL OF VIRAL HEPATITIS

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

(2009) Dongliang Ge et al.   NATURE

IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy

(2009) Vijayaprakash Suppiah et al.   NATURE GENETICS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Poor Response to Pegylated Interferon and Ribavirin in Older Women Infected with Hepatitis C Virus of Genotype 1b in High Viral Loads

(2008) Hitomi Sezaki et al.   DIGESTIVE DISEASES AND SCIENCES

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

(2008) Ming-Lung Yu et al.   HEPATOLOGY

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors

(2008) Haruaki Shirakawa et al.   HEPATOLOGY

Pegylated interferon plus ribavirin for genotype Ib chronic hepatitis C in Japan

(2008) Takayuki Kogure et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Virological Response in Patients with??Hepatitis C Virus Genotype 1b and??a??High Viral Load

(2007) Gotaro Yamada et al.   CLINICAL DRUG INVESTIGATION